Fundz

MBrace Appoints Steve Alley as Chief Scientific Officer

PRIVATEMar 05, 2024

Position

Chief Scientific Officer

Company

MBrace Therapeutics

Steve Alley
salley@mbracetrx.com
San DiegoBiotechnologyHealth CareMedicalTherapeuticsPharmaceutical

Description

MBrace Therapeutics, Inc. appoints Dr. Steve Alley, Ph.D

Quick answer

MBrace Appoints Steve Alley as Chief Scientific Officer (March 5, 2024). MBrace Therapeutics is based in San Diego, California, United States.

Who is the new Chief Scientific Officer at MBrace Therapeutics?
MBrace Therapeutics named Steve Alley Chief Scientific Officer, announced March 5, 2024.
What did MBrace Therapeutics announce on March 5, 2024?
MBrace Therapeutics, Inc. appoints Dr. Steve Alley, Ph.D
What does MBrace Therapeutics do?
MBrace is a clinical stage pharmaceutical company focused on the development and commercialization of novel therapeutic agents for patients with cancer.
Where is MBrace Therapeutics based?
MBrace Therapeutics is based in San Diego, California, United States.
Which similar companies made leadership changes around the same time?
Aculys Pharma (April 1, 2024), Apollomics (March 4, 2024), Elevation Oncology (March 4, 2024) and EyePoint, Inc. (March 4, 2024) also announced leadership changes within 45 days of MBrace Therapeutics.

Source: Fundz verified event record.

Other recent leadership changes in Medical and Therapeutics

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at MBrace Therapeutics, and when

A new leader at MBrace Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day MBrace Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at MBrace Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at MBrace Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

MBrace Therapeutics

Location

San Diego, California, United States

About

MBrace is a clinical stage pharmaceutical company focused on the development and commercialization of novel therapeutic agents for patients with cancer. MBrace develops innovative treatments for cancer patients by developing novel antibody-drug conjugates against targets identified using technology pioneered by its founders. MBrace is headquartered in San Diego, CA, with research facilities at The Thomas O. Daniel Research Incubator and Collaboration Center at Bristol Myers Squibb in Summit, NJ. For additional information, please visit MBrace’s website at http://www.mbracetrx.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment MBrace Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Yongjian
Likely contact at this company
••••••••@••••••••

See Yongjian's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for MBrace Therapeutics's next move

Learn about Strategic plan

MBrace Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.